ARTICLE | Company News
Basilea, Hikma Pharmaceuticals deal
November 16, 2015 8:00 AM UTC
Basilea granted Hikma exclusive rights to commercialize Zevtera ceftobiprole in the Middle East and North Africa. The antibiotic is approved in Europe to treat adults with community-acquired pneumoni...